The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
CRI-CCTG-0003/IND.240: An immunotherapy platform study in platinum-resistant high grade serous ovarian cancer (IPROC).
 
Helen Mackay
Honoraria - AstraZeneca; GlaxoSmithKline
Consulting or Advisory Role - Eisai; GlaxoSmithKline; Merck
 
Anna Tinker
Honoraria - AstraZeneca; Eisai; GlaxoSmithKline Canada; Merck Serono
Consulting or Advisory Role - AstraZeneca
Speakers' Bureau - GlaxoSmithKline
Research Funding - AstraZeneca/MedImmune (Inst)
Travel, Accommodations, Expenses - GlaxoSmithKline
Other Relationship - AstraZeneca
(OPTIONAL) Uncompensated Relationships - GlaxoSmithKline
 
Brad Nelson
Consulting or Advisory Role - Innovakine Therapeutics
Research Funding - Innovakine Therapeutics; Overture Therapeutics
Patents, Royalties, Other Intellectual Property - Innovakine Therapeutics; Overture Therapeutics
 
Dmitriy Zamarin
Stock and Other Ownership Interests - Accurius; Calidi Biotherapeutics; ImmunOs Therapeutics
Consulting or Advisory Role - AstraZeneca; Celldex; Crown Bioscience; Genentech/Roche; GlaxoSmithKline; Hookipa Biotech; Memgen; Synthekine; Targovax; Tessa Therapeutics; Xencor
Research Funding - AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst); Merck (Inst); Plexxikon (Inst); Synthekine (Inst)
Patents, Royalties, Other Intellectual Property - I hold a patent regarding the use of recombinant Newcastle Disease Virus (NDV) for cancer therapy. (Inst)
 
Kunle Odunsi
Leadership - AACR; Cancer Research Institute; Society for Immunotherapy of Cancer
Stock and Other Ownership Interests - Tactiva Therapeutics
Honoraria - KIYATEC
Consulting or Advisory Role - Celsion; Dailchi-Sanyo; GlaxoSmithKline; Regeneron
Research Funding - AstraZeneca; Tesaro
Patents, Royalties, Other Intellectual Property - Roswell
Travel, Accommodations, Expenses - Immunovaccine
 
Stephanie Lheureux
Honoraria - AstraZeneca; GlaxoSmithKline; Merck; Roche/Genentech; Shattuck Labs
Consulting or Advisory Role - AstraZeneca; GlaxoSmithKline; Merck; Novartis; Roche/Genentech; Shattuck Labs
Research Funding - AstraZeneca (Inst); GlaxoSmithKline (Inst); Merck (Inst); Regeneron (Inst); Repare Therapeutics (Inst); Roche/Genentech (Inst); Tesaro (Inst)
 
Susan Ellard
Stock and Other Ownership Interests - Abbvie; AstraZeneca; Bristol-Myers Squibb; GlaxoSmithKline; Merck; Pfizer
Honoraria - AstraZeneca; Bristol-Myers Squibb; Gilead Sciences; GlaxoSmithKline; Merck; Novartis
 
Alannah Smrke
Consulting or Advisory Role - Medison; Merck; Pfizer
 
Pierre-Olivier Gaudreau
Research Funding - AstraZeneca (Inst); AstraZeneca (Inst); AstraZeneca (Inst); Novartis (Inst); Repare Therapeutics (Inst); Repare Therapeutics (Inst)
 
Tess Faulkner
No Relationships to Disclose
 
Ana Rosa Saez-Ibanez
No Relationships to Disclose
 
Dongsheng Tu
No Relationships to Disclose
 
Janet Ellen Dancey
Leadership - 3Ci
Honoraria - 3Ci
Research Funding - AstraZeneca/MedImmune (Inst); Pfizer (Inst); Roche (Inst); Seagen (Inst)